Trade-Related Aspects of Intellectual Property Rights

Trade-Related Aspects of Intellectual Property Rights
Muso · CC BY-SA 3.0 · source
Name	Trade-Related Aspects of Intellectual Property Rights
Date signed	1994
Location signed	Marrakesh Agreement
Parties	World Trade Organization

Trade-Related Aspects of Intellectual Property Rights is a multilateral agreement administered by the World Trade Organization that sets minimum standards for Berne Convention-related copyright and Paris Convention-related patent protection among its members, negotiated during the Uruguay Round and adopted as part of the Marrakesh Agreement in 1994. The agreement binds signatories including United States, European Union, Japan, India, China, and numerous other WTO members and has shaped international negotiations at venues such as the Doha Declaration and disputes adjudicated by the WTO Dispute Settlement Body. It intersects with instruments like the Agreement on Agriculture, GATT 1994, and national statutes such as the Patent Act and the Copyright Act in many jurisdictions.

Overview and History

TRIPS emerged from negotiations in the Uruguay Round under the auspices of the General Agreement on Tariffs and Trade to harmonize standards urged by rights-holders represented by organizations including the International Federation of the Phonographic Industry, the International Publishers Association, and the International Federation of Reproduction Rights Organisations. Delegations from United States Trade Representative, European Commission, Japan Ministry of Economy, Trade and Industry, Brazil, South Africa, India Ministry of Commerce, and China Ministry of Commerce debated provisions influenced by precedents from the Paris Convention for the Protection of Industrial Property and the Berne Convention for the Protection of Literary and Artistic Works. Following ratification via the Marrakesh Agreement, TRIPS became enforceable through the WTO Dispute Settlement Body, reshaping national enactments such as amendments to the United States Copyright Act and the European Patent Convention.

Key Provisions of TRIPS

TRIPS sets substantive rules on patents, including minimum patentable subject matter, patent term of protection, and rights enforcement that affected statutes like the United States Patent Act and instruments such as the European Patent Office practice; on copyright, it mandates protection of literary and artistic works referenced in the Berne Convention and affects institutions such as the British Library and the Library of Congress; on trademarks, geographical indications, industrial designs, trade secrets, and layout-designs for integrated circuits it references mechanisms used by the World Intellectual Property Organization and registries like the United States Patent and Trademark Office. Specific obligations include national treatment, most-favored-nation treatment, and transitional arrangements that influenced policy debates in capitals from Washington, D.C. to New Delhi and in regional bodies such as the European Union and the African Union.

Dispute Settlement and Enforcement

Enforcement under TRIPS relies on the WTO Dispute Settlement Body and remedies can include retaliation and compliance processes which have been invoked in cases involving parties like the United States, the European Communities, Brazil, and India. Prominent disputes have overlapped with national measures litigated before institutions such as the European Court of Justice and the United States Supreme Court when implementing TRIPS-related statutes like the Patent Act or adjudicating actions by companies such as Pfizer, Microsoft, Novartis, and GlaxoSmithKline. Enforcement mechanisms encourage coordination among enforcement agencies, customs authorities, and courts exemplified by cooperation between offices such as the United States Customs Service and the European Anti-Fraud Office.

Flexibilities and Public Health Exceptions

TRIPS contains flexibilities including compulsory licensing, parallel importation, and exceptions for research and teaching that were emphasized in the Doha Declaration on the TRIPS Agreement and Public Health and later operationalized in decisions such as the WTO General Council waiver for export of medicines to Least Developed Countries. These flexibilities have been invoked by members including Brazil, Thailand, South Africa, India, and Malaysia to address public health emergencies and access to medicines produced by firms such as Merck and Roche; they interface with public health initiatives led by World Health Organization and procurement mechanisms like the Global Fund and Gavi, the Vaccine Alliance.

Impact on Developing and Least-Developed Countries

TRIPS obligations prompted legislative changes in countries across regions, affecting industrial policies in Brazil, India, China, South Africa, and many Least Developed Countries that benefited from transitional periods and technical assistance from WIPO and UNCTAD. Economic and social impacts have been debated in studies by institutions such as the World Bank, the International Monetary Fund, OECD, and civil society actors including Médecins Sans Frontières and the Public Citizen organization. Implementation has shaped technology transfer discussions involving corporations like IBM and Siemens and development strategies advanced at forums such as the United Nations Conference on Trade and Development.

Criticisms and Reform Proposals

Critics including Amnesty International, Human Rights Watch, Médecins Sans Frontières, and scholars at Harvard University, Oxford University, University of California, Berkeley, and London School of Economics argue that TRIPS can constrain access to medicines, seed saving, and traditional knowledge, prompting reform proposals ranging from TRIPS-plus renegotiations in bilateral Free Trade Agreements to multilateral amendments advocated at the WTO Ministerial Conference. Reform proposals have been tabled by coalitions involving India, Brazil, South Africa, Kenya, and Ecuador emphasizing technology transfer, preservation of public health safeguards, protection of World Heritage Site-related indigenous knowledge, and differential treatment for Least Developed Countries; alternative models draw on precedents such as the Doha Declaration and campaigns by civil society networks like the Access to Medicine Foundation.

Category:Intellectual property treaties